The Enforcement Directorate (ED) conducted coordinated raids at 7 locations in Chennai connected to Sresan Pharmaceuticals and Tamil Nadu drug control officials, as part of its widening investigation into the toxic Coldrif cough syrup scandal. The operation underscores suspicions of money laundering and regulatory collusion.
Glimpse:
In a major escalation of the Coldrif cough syrup tragedy, the Enforcement Directorate (ED) on Monday raided seven sites in Chennai and Kancheepuram linked to Sresan Pharmaceuticals. The searches targeted the residence of Sresan’s owner G. Ranganathan, the company’s manufacturing unit, and homes/offices of senior officials in the Tamil Nadu Drug Control Department who have been suspended for alleged dereliction of duty. The ED’s probe is under the Prevention of Money Laundering Act (PMLA), investigating whether profits from the sale of adulterated syrups were laundered and whether irregular collusion facilitated the firm’s operations.
The investigation into the Coldrif cough syrup debacle just turned a new corner. The Enforcement Directorate (ED) launched dawn raids across seven locations in Chennai and Kancheepuram, targeting both Sresan Pharmaceuticals and senior state drug control officials implicated in the scandal.
The residence of G. Ranganathan, the Sresan Pharma owner.
The manufacturing facility of Sresan in Sunguvarchatram / Kancheepuram.
Houses and offices of drug control officers in Tamil Nadu former joint director P.U. Karthikeyan, assistant director Deepa Joseph, and drug inspector K. Karthikeyan are among those under scrutiny. They had already been suspended in connection with the case.
Some searches also extended to areas in Chennai’s Kodambakkam, Chromepet, and officials’ homes.
The ED’s involvement is not simply about product safety it’s a money laundering probe. Officials are examining financial trails, possible shell companies, fund diversions, and whether profits from the sale of adulterated syrups were funneled through illicit channels. The ED has filed an Enforcement Case Information Report (ECIR), taking predicate offences from two FIRs: one in Madhya Pradesh for child deaths, and another in Tamil Nadu related to corruption and regulatory failure.
This action reflects growing concerns that the tragedy was enabled not only by toxic drugs, but also by systemic regulatory breakdown and potential collusion. Tamil Nadu’s drug control department itself has come under intense scrutiny for negligence, delayed inspections, and possible complicity in licensing lapses.
“The ED raids are a strong signal: this is not just about contaminated syrups it’s also about uncovering financial wrongdoing and regulatory failure that allowed such a lapse.”
By
HB Team
